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Abstract Childrenof atopicparents arerecognisedasbeingathigherriskofdevelopingbronchialasthma, drawingthe
attention of prevention strategies towards this population.Due to recent advances, lung function abnormalities in asth-
matic childrenmaynowbemeasured early in life.The aimofthis investigationwas to examine possible predictors of lung
function development in a sub sample of high-risk infants who took part in an allergy avoidance study. In 60 babies of
atopic parents, measurements of upper airwaysinflammationwereperformed at 4 weeks of age, respiratory symptoms
were assessed at 6 and12 months of age, and lung function (Vmax,FRC) wasmeasured at18 months by the rapid thora-
coabdominal compression technique.Twenty-eight babies were enrolled in an allergen avoidance program, and 32 re-
cruited as controls. No significant differences were detected for V’max,FRC between the intervention group (mean
331mls1) and the control group (359ml s1), P=0?382. A multiple linear regression model could explain levels of
V’max,FRC by weightgain since birth (beta =35?35mls1kg1, P=0?022) and byeosinophilic cationic protein (ECP) (be-
ta=0?95mls1 ml1, P=0?044), but not by intervention. Lung function measured at the age of 18 months in high-risk
children is associatedwithweightgain andnasal ECP.r2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1254, available online at http://www.idealibrary.comon
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Development of bronchial asthma and allergic disease in
children is believed to be determined very early in life.
Exposure to house dustmite (HDM) allergens in early in-
fancy is also believed to be an important trigger in sensi-
tisation and development of atopic disease (1). Avoidance
of allergen exposure in early life has been demonstrated
to increase the threshold of sensitisation, at least in
‘‘high-risk’’ children (2). However, besides the known ef-
fects of HDM allergen avoidance on sensitization, and
besides anecdotal evidence, little is known about the ef-
fects of HDM allergen reduction on the development of
lung function in infants.
Eosinophilic airway in£ammation has been demon-
strated to be associated with bronchial asthma (3).
Moreover, elevated levels of eosinophilic cationic protein
(ECP) in serum during an early episode of wheezing hasReceived 6 March 2001and accepted in revised form 5 November 2001.
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bronchial asthma in young children (4). Recently, upper
airways eosinophil in£ammation in the ¢rst 4 weeks of
life was demonstrated to be a risk factor for the devel-
opment of recurrentwheeze in 6-month-old infants (5).
There is ongoing interest inmeasurementof lung func-
tion in infants, and its relationship to respiratory symp-
toms (6,7). Studies have found that diminished lung
function may occur in currently symptom-free infants,
before the onset of respiratory symptoms. This might
be interpreted as a result of subclinical airway in£amma-
tion, eventually resulting in bronchial asthma.
Furthermore, a growing body of evidence shows an
association between body composition and the develop-
ment of asthma: studies have found a relationship be-
tween foetal growth and asthma (8), and also between
obesity and asthma (9).
This study was performed to determinewhether lung
function at the age of 18 months was associated with
neonatal upper airways in£ammation or weight gain in
infancy. Furthermore, we analysed whether simple
methods of HDM allergen reduction in£uenced lung
function development in ‘‘high-risk’’ infants.
LUNGFUNCTIONININFANTSATHIGHRISKOFATOPY 231METHODS
Study population and allergen avoidance
All children were participating in an international multi-
centre study (Study on the Prevention of Allergy in Chil-
dren in Europe, SPACE, Biomed II program) aimed at the
prevention of allergy by means of dust mite avoidance
measures (5). Mothers were enrolled either at routine
visits at two obstetric wards in Vienna (Vienna general
hospital, SMZ-Ost) during pregnancy or shortly after
birth at the children’s departments of the centres in-
volved. Screening questionnaires for symptoms asso-
ciated with allergic disease were distributed and if a
history of allergic rhinitis, hayfever, bronchial asthma or
eczema was reported by any parent, skin-prick testing
or serum IgE measurement were performed. Families
were included if there was a positive allergy history and
positive allergy test (toDermatophagoides pteronyssinnus,
D farinae, birch, ryegrass, ragweed or cat) in any parent.
After birth, participating infants were randomized
into the intervention or control groups. Parents of the
intervention group were encouraged to adhere to the
following house dustmite avoidance procedures:
K Allmattresses in the child’s room should be covered
with special dustmite protection casings (ACbs,Dr,
Beckmann GmbH, Seefelden,Germany).
K Carpets in the child’s room should be removed and
curtains that can be hot-washed should be selected.
K Soft toys and bedding should be hot-washed or
frozen (weekly) as well as pillows and blankets.
K The child’s room should be ventilated whenever
possible.
K The use of a damp cloth was advised when dusting
and vacuum cleaning, which should be done once a
week in the absence of the child.
K Smoking was discouraged in the house, as well as
pets. If pets were present they were not allowed in
the child’s bedroom.
K Exclusive breast feeding was recommended for as
long as possible and for at least 3 months.
K Introduction of solid foods was delayed until at least
4months,milk products and cow’smilk formula until
at least 6months. If supplementationwas required, a
hypoallergenic formula was recommended before 6
months.
K Cow’s milk, egg and ¢sh were recommended not to
be introduced to the child’s diet before 12 months
and peanut or tree nuts before the age of 3 years.
Implementation of these suggestions was checked at
home visits at the age of1, 6 and12 months. In contrast,
only brief standard recommendations from the relevant
Austrian authorities were reiterated to parents for in-
fants in the control group: breast-feeding was encour-
aged for at least 3 months, cow’s milk wasrecommended to delay until the twelfth month of life
and the avoidance of pets and cigarette smoke was ad-
vised.
After 6 and 12 months children were seen again at
their homes and a questionnaire regarding symptoms
likely to be associated with allergy was ¢lled out by the
parents. In addition, data on smoking during pregnancy
and smoking in the presence of the child were collected.
After the 12 months home visit, parents were asked
for consent to participate in this study on lung function
measurements. We recruited 62 subjects, and pulmon-
ary function tests (PFT) could subsequently be per-
formed in 60 of them, with the remaining babies failing
to sleep during themeasurements.Thirty-two of the ba-
bies (19 boys, 13 girls) were allocated to the control
group, and 28 (14 boys,14 girls) to the interventiongroup.
Informed consent was obtained from the parents prior
to all measurements and the study protocol was ap-
proved by Vienna University’s Ethical Committee.
Nasal lavage
Families were visited when the child was healthy as
judged by the parents within the ¢rst 4 weeks of life
(mean age 20?5 days, SD 7?6). Nasal lavage was thus per-
formed at the children’s homes. After inspection of the
nasal lavage £uid, children were de¢ned as being free of
rhinitis, having serous rhinitis or having purulentrhinitis.
Nasal lavage was obtained by instilling 2ml of 371C phy-
siologic saline solution via syringe into each nasal cavity
with the baby lying supine. Wash £uid and secretions
were immediately aspirated into a sterile specimen trap
[tracheal suction set (Fa.Dahlhausen) and a 30 cm suction
catheter (Fa.Uno) attached to a portable suction device
(Atmos LC-16,Fa.Draeger)]. The sampleswere then pro-
cessed in a standardizedway. They were ¢rstly left for at
least 1h at room temperature. Samples were then
weighed and diluted1:1with Dithiothreitol (Cleland’s re-
agent, Biorath/Germany). They were then centrifuged at
1454g for 10 min at room temperature. Cells were dis-
carded and the supernatants were stored at 301 until
analysis. Supernatant was subsequently analysed for eo-
sinophil cationic protein (ECP) and EPX. Results are gi-
ven in mgl1 after correction for dilution. Eight medical
students previously trained in the procedure performed
all the lavages (5).
Pulmonary function tests (PFT)
Pulmonary function tests were scheduled for18 months
of age. The children had to be free of upper airway infec-
tion 3 weeks prior to testing. Pulmonary function tests
were performedby utilising the rapid thoracoabdominal
compressions (RTC) technique, using the SensorMedics
SM2600 System (SensorMedics Corporation, Yorba
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device (Equilibrated Bio Systems, Inc., Melville NY,USA).
This system is described in detail elsewhere (10,11). Mea-
surements were performedwith the infant in the supine
position, sedatedwith chloral hydrate (75mgkg1 body-
weight). Flow was measured with a pneumotachograph
(4500 series, Hans Rudolph, MO, USA), linear for the
range 0^100 lmin1).
The infant’s upper body was wrapped into an in£ata-
ble jacket. The pneumotachopraph was attached to the
face via a facemask (Vital-Signs, Inc, USA). To avoid air
leaks, themask functionwas improvedwith an in£atable
cu¡, andwhole system dead spacewas kept to 20ml.
Tidal breathing of the infant was observed on the
computer screen in the form of a £ow^volume curve.
Before performing an RTC-manoeuvre, at least six pre-
ceding tidal volume £ow^volume curves had to be
superimposable, suggesting reproducible tidal volume
and end-expiratory level. Four RTCwere performed be-
ginningwith a jacketpressure of 40 cmH2O, and at pres-
sures of 60, 80, and 100 cm H2O. Maximal £ow at
functional residual capacity (V’max,FRC) was calculated as
themean of the threemanoeuvres, presenting the high-
est £ow at FRC in technically acceptable curves at the
jacket pressurewhich gave the highest £ow (12).
Weight and height was recorded prior to the mea-
surements.Weight was measured with a calibrated digi-
tal scale with the children naked. Length was measured
with the children standing upright by two investigators.
Statistics
Before investigating the datawe ensured that the sample
was representative of the remainder of the SPACE study.
When viewing metric parameters (e.g. ECP, EPX, birth-
weight, etc.)we applied the two sided t-test asboth sam-
pleswere large enough to assumenormalityof themean.TABLE 1. Descriptive data ofthe 60 study subjects
All subjects
Mean SD
Weightgain since birth (kg) 7?86 0
Weight (kg) 11?29
Height (cm) 80?90
Age (months) 17?6
V’max.FRC (mls
1) 346?14 12
Median 5th^95th p
ECP (mgl1) 5?02 0^174
EPX (mgl1) 9?58 0^153
number
Respiratory symptoms 46
Wheezing 34
Eczema 10Whenever the comparison referred to categorical
variables (e.g. symptoms, social status), the w2 test was
used to draw comparisons.
We estimated the required sample size to give a
power of 0?8, and P value of 0?05. Based on preliminary
studies and the curent literature (6,7,12),we expected the
VmaxFRC-values for the infants in the intervention group
at 370ml s1 and with an SD of 100ml s1, and the ex-
pected control group by a mean of 20% below the inter-
vention group (297ml s1). Both VmaxFRC-values ware
expected for children at height 80 cm. Consecutively, a
sample size of 30 per groupwas estimated.
The comparison ofmetric parameters between inter-
vention and control group in infants with PFTwas drawn
via a two sided t-test. In a similarmanner w2 tests for this
population were applied for detection of di¡erences in
symptom frequency, social status etc in the two groups.
General linear regression analyses were applied to
analyse several potentially in£uential and confounding
parameters on the primary outcome variable of lung
function.
All statistical analyseswere carriedoutusing SAS,Ver-
sion 6.11.
RESULTS
Therewere no signi¢cant di¡erences between the 60 in-
fants recruited for PFTand the remaining 340 infants of
the SPACE study in terms of the following parameters:
ECP, EPX, birthweight, respiratory symptoms prior to
PFT, parental smoking or parental history of atopy. Of
the PFT participants,11were a¡ected by smoking during
pregnancy and15 by passive smoke exposure.For 46, re-
spiratory symptoms within the ¢rst 18 months of life
were reported (Table1).
Within the infants who underwent PFT, infants in the
intervention grouphad a signi¢cantly higher birthweightControlgroup Intervention group
Mean Mean
?99 7?77 7?89
1?19 11?34 11?12
2?63 80?91 80?90
1?13 17?6 17?7
0?53 359?12 333?35
ercentile
?56 4?69 5?10
?58 9?73 9?55
number number
22 24
15 19
7 3
Weight-gain (kg)
1098765
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FIG. 1. Negative linear relationship between V’max,FRC and
weight-gain:R=0?297, P=0?021.
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P=0?01), while no di¡erences were detected for ECP,
EPX, respiratory symptoms prior to PFT, weight-gain
parental smoking or parental history of atopy.
No signi¢cant di¡erences were detected for V’max,FRC
between the intervention group (mean 331ml s1) and
the control group (359ml s1), P=0?382.
In a correlation analysis, V’max,FRC was correlated to
weight gain (R=0?297, P=0?021), but not to ECP (Fig. 1).
ECP was correlatedwith EPX (R=0?911, P=0?001).
V’max,FRC was the dependent variable in our model of
multiple linear regressions.We detected signi¢cant nega-TABLE 2. Multiple linear regression onV’max,FRC (mls
1) at18 m
controlgroup and the intervention group (P-values and 95% con
Independent variables b
(95% CI)
for all subjects
P
Weightgain (kg) 52?400
(48?326^57?968)
0
Birthweight (kg) 2?400
0?911^7?220)
Height (cm) 8?188
(3?101^11?440)
Smoking (non-smoking=0) 19?895
(11?878^22?551)
0
Sex (male=0) 8?309
(7?109^11?222)
ECP (mgl1) 0?945
(0?987^0?891)
0
EPX (mgl1) 0?915
(0?798^0?981)
Respiratory symptoms
(no symptoms=0)
38?279
(16?001^49?281)
Intervention orcontrolgroup
(control = 0)
1?558
(1?229^1?971)
0tive relationships between V’max,FRC and weight gain as
well aswith ECP. In contrast, therewas no signi¢cant re-
lationship between V’max,FRC and height, smoking, sex,
respiratory symptoms or allocation to either the inter-
vention or the control group. (For results of linear re-
gressions seeTable 2.)
DISCUSSION
In our cohort, the strongest predictors of lung function
developmentwereweight gain since birth and ECP in na-
sal lavage at 4weeks of age.Fromourmultiple regression
model, aweightgain of1kgwas associatedwith a decline
of V’max,FRC of 53ml s
1, and an increase of ECP in nasal
lavage of 1mgl1 was associated with a decline of
V’max,FRC of 1ml s
1. In contrast, lung function levels at
the age of 18 months were statistically not explained by
the allocation to either the allergen avoidance or the
control group.
There are some limitations of our study design, re-
garding PFTas a tool tomeasure e¡ectiveness of allergen
avoidance. First, one might argue that, because of the
high degree of intrasubject variability for the tidal vo-
lume RTC technique, we should have performed PFT by
raised volume RTC. However, this approach seemed to
be too invasive for our subjects in the view of our hospi-
tal’s ethical committee.Furthermore, a larger number of
subjects would have givenmore statistical power to our
results.Unfortunately theneed for sedation reducedouronths for all subjects as well as seperately for subjects in the
¢dence intervals only for all subjects)
value b
for controlgroup
b
for intervention group
?022 53?400 51?250
0?822 3?422 1?002
0?326 8?234 8?0129
?600 17?309 25?002
0?803 5?309 11?226
?044 0?991 0?829
0?062 1?034 0?803
0?298 41?231 44?561
?096 1?316 1?759
234 RESPIRATORYMEDICINErecruitment rate down to15% of the participants of the
SPACE-study.However, basedon our sample size calcula-
tion, our numbers were large enough to detect a clini-
cally relevant di¡erence of 20% between the groups.
Quantitative analysis of mite antigen concentrations in
matresses would also have helped with measureing the
results of the avoidanceprocedures. Surely, poor compli-
ance can have e¡ected lung function development also.
Likewise, subjects of the control group may have per-
formed energy avoidance strategies on their own (wild
intervention). However, the e¡ectiveness of the regime
will be tested again in the future, when sensitization
rates and in£ammationmarkers will be available.
We found a negative linear relationship between ECP
in nasal lavage and V’max,FRC, suggesting lung function at
18 months is already determinedby airway in£ammation
soon after birth. This is in agreement with ¢ndings of a
predictive value of ECP in nasal lavage for development
of respiratory symptoms in the ¢rst 6 months of life
within the entire Austrian SPACE cohort (5). However,
the association of ECP and V’max,FRCwas not detectable
in a univariate model, and EPX, which is strongly corre-
lated with ECP, was not associated withV’max,FRC in our
multiple linear model. Moreover, although statistically
signi¢cant the relationship may be of minimal clinical re-
levance.Therefore, our ¢ndings can only be interpreted
as showing a very weak association between post-natal
airway in£ammation and lung function at 18 months of
age.
Themost interesting ¢nding of our study remains the
relationship between V’max,FRC and weight gain. In pre-
vious studies, in£uences of foetal growth on the intrau-
terine programming of the respiratory and immune
system (8) have been suggested. Since our study was
not designed to elucidate intrauterine developments we
are limited when speculating about possible foetal ef-
fects on lung function.However, birthweightwas not as-
sociated with lung function in our subjects, suggesting
that post-natal growth was mainly responsible for our
results. Asmentioned earlier, performing PFTsoon after
birthwouldhavegivenmore information for thatdebate.
Epidemiological studies in both children (13,14) and
adults (15) have foundrelationshipsbetweenbodyweight
and asthma. In these studies and age groups, it remains
unclear whether theserelationships arereal associations
or biased by confounders such as lifestyle or physical ac-
tivity. In a similar way, we can only speculate whether
these relationships are due to a causal association (16).
Our study was initially not designed to measure body
weight as an outcome and there are limitations when in-
terpreting our results. In adults or older children, life-
style issues like physical exercise will certainly confound
¢ndings of asthma and body weight, though it is un-
known whether these issues play a major role in infants
younger than1?5 years of age.Questions about whether
asthma causes obesityorwhether obesitycauses asthmahave not been adequately answered in adult or adoles-
cent groups (16).We can add the following ¢nding from
our study to that debate: the relationship between lung
function andweight starts veryearly in life.To investigate
these ¢ndings, further controlled studies are needed, in-
cluding pre- and post-natal anthromopometrical mea-
surements andmore detailed nutritional information.
In summary, we have shown that lung function at the
age of18 monthsmay be determinedby upper airway in-
£ammation and weight gain.Our allergen avoidance re-
gime, as described, did not signi¢cantly in£uence lung
function.
When identifying very young children at high risk for
atopy, notonlyparental atopybut also high infantweight-
gainmight be perceived as a risk factor.
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